发明申请
US20100049273A1 USE OF LATE PASSAGE MESENCHYMAL STEM CELLS (MSCS) FOR TREATMENT OF CARDIAC RHYTHM DISORDERS
审中-公开
用于治疗心脏疾病的最常用的中枢神经干细胞（MSCS）的使用
- 专利标题： USE OF LATE PASSAGE MESENCHYMAL STEM CELLS (MSCS) FOR TREATMENT OF CARDIAC RHYTHM DISORDERS
- 专利标题（中）： 用于治疗心脏疾病的最常用的中枢神经干细胞（MSCS）的使用
-
申请号： US12374030申请日： 2007-07-20
-
公开(公告)号： US20100049273A1公开(公告)日： 2010-02-25
- 发明人: Glenn Gaudette , Irina A. Potapova , Peter R. Brink , Ira S. Cohen , Richard B. Robinson , Michael R. Rosen
- 申请人： Glenn Gaudette , Irina A. Potapova , Peter R. Brink , Ira S. Cohen , Richard B. Robinson , Michael R. Rosen
- 国际申请： PCT/US2007/016430 WO 20070720
- 主分类号： A61N1/02
- IPC分类号： A61N1/02 ; C12N5/071 ; A61K45/00 ; A61P9/00
摘要：
The present invention provides methods and compositions relating to the use of late passage mesenchymal stem cells (MSCs) for treatment of cardiac rhythm disorders. The late passage MSCs of the invention may be used to provide biological pacemaker activity and/or provide a bypass bridge in the heart of a subject afflicted with a cardiac rhythm disorder. The biological pacemaker activity and/or bypass bridge may be provided to the subject either alone or in tandem with an electronic pacemaker.